Procedure May Relieve Agony of Spinal Cord Injuries

JULY 01, 2004

Molecular neurosurgery may someday offer pain relief to patients with spinal cord injuries. A study, reported recently in the on-line edition of Neuroscience Letters, found that a potent neurotoxin eliminated pain-transmitting rogue nerve cells that caused chronic pain in rats with paralyzing spinal cord injuries. In molecular neurosurgery, the neurotoxin acts on specific sites in the spinal cord, where the neurotoxin is incorporated into nerve cells, which then die.

The findings may help researchers better grasp the mechanisms of pain experienced by individuals after a spinal cord injury. Statistics have shown that up to 80% of individuals with spinal cord injuries develop some form of chronic pain at or below the level of paralysis.



SHARE THIS SHARE THIS
0
 

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.